Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 7356 matches for

An internationally recognised centre of excellence for biomedical and clinical research and teaching

The genetic basis of fertility, family and longevity

A new review by researchers from Oxford Population Health and the University of Iceland, published in Nature Aging, reveals how your DNA shapes reproductive health, fertility, and even life expectancy.

Can we get to overseas conferences without wrecking the planet?

Two Oxford researchers share their eye-opening journey to a conference in Marrakesh by train and ferry instead of flying. Discover the challenges, unexpected joys, and compelling environmental case for low-carbon academic travel.

Mei Nortley awarded inaugural Averil Mansfield Trainer of the Year Award

Ms Mei Nortley, Deputy Director of Teaching in Surgery at the Nuffield Department of Surgical Sciences, has been presented with the inaugural Averil Mansfield Trainer of the Year Award 2024.

Alethiomics – using Artemis to hunt down blood cancers

Spin-out company Alethiomics, focused on the development of innovative treatments for blood cancers, is Oxford through-and-through. Founded by Clinician Scientists who run neighbouring laboratories at the University’s MRC Weatherall Institute of Molecular Medicine, seed financed by Oxford Science Enterprises and located at the BioEscalator, the company’s early years have been immersed in the Oxford innovation ecosystem.

Research Excellence Framework (REF) Panel Update

Oxford and partners lead on two new MRC Centres to create cutting-edge gene therapies

Oxford University researchers are to lead and co-lead on two MRC research centres, which are being launched to develop new advanced treatments for currently untreatable diseases.

MSD Research Staff Forum update: Sharing activities that help researchers

First vaccine against blood-stage malaria is well-tolerated and offers effective protection

The results of a clinical trial into a new malaria vaccine candidate (RH5.1/Matrix-MTM) show it is well-tolerated and offers effective protection against the blood-stage of the disease - the first inoculation to do so.

The Kavli Oxford Lecture Award 2024 Recognises Regina E. Dugan for Breakthroughs in Human Health Innovation

The Kavli Oxford Lecture Award, an annual celebration of scientific achievement and inspiration, marked its third year with a captivating keynote delivered by Regina Dugan, CEO of Wellcome Leap. A pioneering leader in health innovation, Regina inspired the audience by demonstrating how differences could be made by accelerating breakthroughs in human health.

Wearable devices can help predict five year risk of falls for people with Parkinson’s Disease

A new study from the University of Oxford demonstrates how clinicians could use data to predict the risk of falls in people with Parkinson’s Disease (PD) to help improve effective longer term care planning.

Predicting Response to Rectal Cancer Treatment through the S:CORT consortium

Recent research from the S:CORT team spanning three publications has identified key biomarkers and treatment strategies that predict and enhance effectiveness of radiotherapy in rectal cancer treatment.

Department of Pharmacology research leads to FDA approval for new NPC treatment

A Department of Pharmacology start-up company has received approval from the US Food and Drug Administration (FDA) for a new treatment for the rare lysosomal storage disorder Niemann-Pick Disease Type C (NPC) in both adults and children.

Renewal of the Novo Nordisk – University of Oxford Fellowship Programme

Leading global healthcare company Novo Nordisk has deepened its partnership with the University of Oxford by announcing £18.5 million of funding for a further 20 Postdoctoral Fellows in this prestigious scientific research programme, over the next nine years. This expanded collaboration also introduces an innovative ‘Springboard Fellowship’, which offers selected fellows an extra two years of funding to further advance their research and professional development.

David Clark and Anke Ehlers win 2024 Mohammed bin Rashid Al Maktoum Knowledge Award for mental health research

It is the first time that the award, which recognises exceptional achievements in knowledge and innovation, has been awarded for mental health research.

Study of menstrual tracking app usage highlights potential role in improving access to reproductive health services

A new study by researchers in the UK and Denmark, published in Digital Health, provides the first publicly accessible analysis of global downloads for menstrual tracking apps.

Professor Anthony Harnden appointed as the new Chair of the Medicine and Healthcare products Regulatory Agency (MHRA)

Professor Anthony Harnden, of Nuffield Department of Primary Care Health Sciences, University of Oxford, and former Deputy Chair of the Joint Committee on Vaccination and Immunisation (JCVI), has been appointed Chair of the UK’s Medicines and Healthcare products Regulatory Agency (MHRA).

Bodleian Libraries Update - Nov 2024 - Open Access Focus Group | Worry Box | Say it with Science | Support and Events

Warneford Park: invite to second phase of consultation

Four Oxford academics receive ERC Synergy Grants to address complex scientific problems

Four Oxford University academics are to co-lead ambitious new research projects backed by European Research Council (ERC) Synergy Grants, part of the EU’s Horizon Europe research and innovation programme. Synergy Grants foster interdisciplinary and international collaboration between outstanding researchers, enabling them to combine their expertise, knowledge, and resources to push the boundaries of scientific discovery.

MyMelanoma study selected to join NHS DigiTrials initiative

Three projects – including the Oxford-led MyMelanoma study - have been selected to join an NHS initiative, which aims to sign up tens of thousands of volunteers over the next two years to help improve the diagnosis and treatment of cancer patients.

Load More